VL2397-201: A Phase 2 Study of VL-2397 Compared to Stand

Project: Research project

Project Details

Description

VL2397-201: A Phase 2 Study of VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis in Adults with Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, or Allogeneic Hematopoietic Cell Transplant Recipients
StatusActive
Effective start/end date12/1/1712/31/20

Funding

  • Vical Incorporated

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.